Abstract
The pharmacokinetic and pharmacodynamic interactions between diltiazem and propranolol, or atenolol were investigated in healthy volunteers. Diltiazem (30mg) or placebo was given three times daily for 3 days, and 30 min before administration of a β-adrenoceptor blocking drug given on the 4th day. A single dose of propranolol (20mg), or atenolol (50mg) was administered in a randomized, double-blind, crossover fashion. Exercise tests on a cycle ergometer were carried out before and after β-adrenoceptor blocking drug. Diltiazem significantly increased the AUC and elimination half-life of propranolol. The cardiac β-adrenoceptor blocking effect, as indicated by the percentage reduction in heart rate during exercise, tended to increase following diltiazem pretreatment, in comparison with placebo. In contrast, diltiazem did not significantly affect atenolol pharmacokinetics and pharmacodynamics. These results indicated that diltiazem impaired the total clearance of propranolol, which is principally metabolized by oxidative pathway in the liver. This kinetic interaction between diltiazem and propranolol may be partly related to the reduction in exercise-induced tachycardia.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
